These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10109993)

  • 1. The long debate on the sixth guaiac test: time to move on to new grounds.
    Gatsonis C
    J Health Econ; 1990; 9(4):495-7. PubMed ID: 10109993
    [No Abstract]   [Full Text] [Related]  

  • 2. The sixth stool guaiac test: $47 million that never was.
    Brown K; Burrows C
    J Health Econ; 1990; 9(4):429-45. PubMed ID: 10109990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.
    Ko CW; Dominitz JA; Nguyen TD
    Am J Med; 2003 Aug; 115(2):111-4. PubMed ID: 12893396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal occult blood test in colorectal cancer screening.
    Li JN; Yuan SY
    J Dig Dis; 2019 Feb; 20(2):62-64. PubMed ID: 30714325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.
    Wong BC; Wong WM; Cheung KL; Tong TS; Rozen P; Young GP; Chu KW; Ho J; Law WL; Tung HM; Lai KC; Hu WH; Chan CK; Lam SK
    Aliment Pharmacol Ther; 2003 Nov; 18(9):941-6. PubMed ID: 14616158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do we gain from the sixth stool guaiac?
    Neuhauser D; Lewicki AM
    N Engl J Med; 1975 Jul; 293(5):226-8. PubMed ID: 1143302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis.
    Vart G; Banzi R; Minozzi S
    Prev Med; 2012 Aug; 55(2):87-92. PubMed ID: 22634386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: faecal occult blood testing for colorectal cancer.
    Allison JE
    Aliment Pharmacol Ther; 1998 Jan; 12(1):1-10. PubMed ID: 9692694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Fletcher RH; Ransohoff DF; Imperiale TF
    Cancer; 2007 May; 109(9):1925-6; author reply 1926. PubMed ID: 17370313
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal Cancer Screening: Which Test Is Best?
    Inadomi JM
    JAMA Oncol; 2016 Aug; 2(8):1001-3. PubMed ID: 27305648
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunochemical versus guaiac fecal occult blood tests.
    Technol Eval Cent Assess Program Exec Summ; 2004 Jul; 19(5):1-3. PubMed ID: 15473055
    [No Abstract]   [Full Text] [Related]  

  • 15. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
    Trojan J; Povse N; Schröder O; Stein J
    Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
    Goede SL; Rabeneck L; van Ballegooijen M; Zauber AG; Paszat LF; Hoch JS; Yong JH; Kroep S; Tinmouth J; Lansdorp-Vogelaar I
    PLoS One; 2017; 12(3):e0172864. PubMed ID: 28296927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacing guaiac-based tests with immunochemical tests in colorectal cancer screening.
    Schlackman N
    Am J Med; 2003 Aug; 115(2):154; author reply 154-5. PubMed ID: 12893403
    [No Abstract]   [Full Text] [Related]  

  • 19. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience.
    Zappa M; Castiglione G; Paci E; Grazzini G; Rubeca T; Turco P; Crocetti E; Ciatto S
    Int J Cancer; 2001 Apr; 92(1):151-4. PubMed ID: 11279619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal occult blood tests in occult gastrointestinal bleeding.
    Bond JH
    Semin Gastrointest Dis; 1999 Apr; 10(2):48-52. PubMed ID: 10361895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.